|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010.
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.
|
|
3
|
Xu C, Zhou W, Wang Y and Qiao L: Hepatitis
B virus-induced hepatocellular carcinoma. Cancer Lett. 345:216–222.
2014.
|
|
4
|
Guerrieri F, Belloni L, Pediconi N and
Levrero M: Molecular mechanisms of HBV-associated
hepatocarcinogenesis. Semin Liver Dis. 33:147–156. 2013.
|
|
5
|
Liu LP, Liang HF, Chen XP, et al: The role
of NF-kappaB in Hepatitis b virus X protein-mediated upregulation
of VEGF and MMPs. Cancer Invest. 28:443–451. 2010.
|
|
6
|
Xia L, Huang W, Tian D, et al: Upregulated
FoxM1 expression induced by hepatitis B virus X protein promotes
tumor metastasis and indicates poor prognosis in hepatitis B
virus-related hepatocellular carcinoma. J Hepatol. 57:600–612.
2012.
|
|
7
|
Barclay JL, Tsang AH and Oster H:
Interaction of central and peripheral clocks in physiological
regulation. Prog Brain Res. 199:163–181. 2012.
|
|
8
|
Eckel-Mahan K and Sassone-Corsi P:
Metabolism and the circadian clock converge. Physiol Rev.
93:107–135. 2013.
|
|
9
|
Li JD, Hu WP and Zhou QY: The circadian
output signals from the suprachiasmatic nuclei. Prog Brain Res.
199:119–127. 2012.
|
|
10
|
Dibner C, Schibler U and Albrecht U: The
mammalian circadian timing system: organization and coordination of
central and peripheral clocks. Annu Rev Physiol. 72:517–549.
2010.
|
|
11
|
Mazzoccoli G, Pazienza V and Vinciguerra
M: Clock genes and clock-controlled genes in the regulation of
metabolic rhythms. Chronobiol Int. 29:227–251. 2012.
|
|
12
|
Isojima Y, Okumura N and Nagai K:
Molecular mechanism of mammalian circadian clock. J Biochem.
134:777–784. 2003.
|
|
13
|
Eide EJ and Virshup DM: Casein kinase I:
another cog in the circadian clockworks. Chronobiol Int.
18:389–398. 2001.
|
|
14
|
Greene MW: Circadian rhythms and tumor
growth. Cancer Lett. 318:115–123. 2012.
|
|
15
|
Savvidis C and Koutsilieris M: Circadian
rhythm disruption in cancer biology. Mol Med. 18:1249–1260.
2012.
|
|
16
|
Brudnowska J and Pepłońska B: Night shift
work and cancer risk: a literature review. Med Pr. 62:323–338.
2011.(In Polish).
|
|
17
|
Leonardi GC, Rapisarda V, Marconi A, et
al: Correlation of the risk of breast cancer and disruption of the
circadian rhythm (Review). Oncol Rep. 28:418–428. 2012.
|
|
18
|
Relles D, Sendecki J, Chipitsyna G, Hyslop
T, Yeo CJ and Arafat HA: Circadian gene expression and
clinicopathologic correlates in pancreatic cancer. J Gastrointest
Surg. 17:443–450. 2013.
|
|
19
|
Lin YM, Chang JH, Yeh KT, et al:
Disturbance of circadian gene expression in hepatocellular
carcinoma. Mol Carcinog. 47:925–933. 2008.
|
|
20
|
Edge SB, Byrd DR, Compton CC, et al: AJCC
Cancer Staging Manual. 7th edition. Springer; New York, NY:
2010
|
|
21
|
Menegaux F, Truong T, Anger A, et al:
Night work and breast cancer: a population-based case-control study
in France (the CECILE study). Int J Cancer. 132:924–931. 2013.
|
|
22
|
Lahti T, Merikanto I and Partonen T:
Circadian clock disruptions and the risk of cancer. Ann Med.
44:847–853. 2012.
|
|
23
|
Chen R, Yang K, Zhao NB, et al: Abnormal
expression of PER1 circadian-clock gene in oral squamous cell
carcinoma. Onco Targets Ther. 5:403–407. 2012.
|
|
24
|
Mazzoccoli G, Panza A, Valvano MR, et al:
Clock gene expression levels and relationship with clinical and
pathological features in colorectal cancer patients. Chronobiol
Int. 28:841–851. 2011.
|
|
25
|
Canaple L, Kakizawa T and Laudet V: The
days and nights of cancer cells. Cancer Res. 63:7545–7552.
2003.
|
|
26
|
Schibler U: The daily timing of gene
expression and physiology in mammals. Dialogues Clin Neurosci.
9:257–272. 2007.
|
|
27
|
Filipski E, Subramanian P, Carrière J,
Guettier C, Barbason H and Levi F: Circadian disruption accelerates
liver carcinogenesis in mice. Mutat Res. 680:95–105. 2009.
|
|
28
|
Logan RW, Zhang C, Murugan S, et al:
Chronic shift-lag alters the circadian clock of NK cells and
promotes lung cancer growth in rats. J Immunol. 188:2583–2591.
2012.
|
|
29
|
Karantanos T, Theodoropoulos G, Gazouli M,
et al: Expression of clock genes in patients with colorectal
cancer. Int J Biol Markers. 28:280–285. 2013.
|
|
30
|
Yang X, Wood PA, Ansell C and Hrushesky
WJ: Circadian time-dependent tumor suppressor function of period
genes. Integr Cancer Ther. 8:309–316. 2009.
|
|
31
|
Hwang-Verslues WW, Chang PH, Jeng YM, et
al: Loss of corepressor PER2 under hypoxia up-regulates
OCT1-mediated EMT gene expression and enhances tumor malignancy.
Proc Natl Acad Sci USA. 110:12331–12336. 2013.
|
|
32
|
Lee CC: Tumor suppression by the mammalian
Period genes. Cancer Causes Control. 17:525–530. 2006.
|
|
33
|
Chen-Goodspeed M and Lee CC: Tumor
suppression and circadian function. J Biol Rhythms. 22:291–298.
2007.
|
|
34
|
Fu L, Pelicano H, Liu J, Huang P and Lee
C: The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50.
2002.
|
|
35
|
Wood PA, Yang X and Hrushesky WJ: Clock
genes and cancer. Integr Cancer Ther. 8:303–308. 2009.
|
|
36
|
Im JS, Jung BH, Kim SE, Lee KH and Lee JK:
Per3, a circadian gene, is required for Chk2 activation in human
cells. FEBS Lett. 584:4731–4734. 2010.
|
|
37
|
Vinciguerra M, Mazzoccoli G, Piccoli C,
Tataranni T, Andriulli A and Pazienza V: Exploitation of host clock
gene machinery by hepatitis viruses B and C. World J Gastroenterol.
19:8902–8909. 2013.
|
